Curi Bio Revenue and Competitors

Seattle, WA USA

Location

#5762

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Curi Bio's estimated annual revenue is currently $4M per year.(i)
  • Curi Bio's estimated revenue per employee is $77,500
  • Curi Bio's total funding is $16M.

Employee Data

  • Curi Bio has 52 Employees.(i)
  • Curi Bio grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M6200%N/AN/A
#2
$1.1M7-36%N/AN/A
#3
$4.8M3119%N/AN/A
#4
$1.3M17-23%N/AN/A
#5
$31.6M1633%$30.2MN/A
#6
$1.9M120%N/AN/A
#7
$4.2M27-16%N/AN/A
#8
$2.5M16-27%N/AN/A
#9
$0.9M60%N/AN/A
#10
$2.8M180%N/AN/A
Add Company

Curi Bio is accelerating the discovery of the next generation of medicines by integrating human cells, systems, and data.

keywords:N/A

$16M

Total Funding

52

Number of Employees

$4M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Curi Bio News

2022-04-19 - New miniature heart could help speed heart disease cures

... to start a new position with Seattle-based biotech Curi Bio, ... "Christos is someone who understands the biology," says White,...

2022-03-22 - Curi Bio Acquires CarTox™ Technology from StemBioSys ...

Curi Bio's preclinical discovery platform combines human stem cells, systems, and data to accelerate the discovery of new medicines. The Curi...

2021-03-19 - Curi Bio Raises $6M in Series A Financing

Curi Bio Inc., a Seattle, WA-based developer of human stem cell-based platforms for drug discovery, raised $6m in Series A financing round. The round, led by Dynamk Capital, is expected to close with additional investors by the end of Q2 2021. With this financing round, Dr. Gustavo Mahler, Mana ...

2021-03-19 - Seattle stem cell startup Curi Bio raises $6M

Curi Bio Chief Business Officer Elliot Fisher and CEO Michael Cho. (Curi Bio Photos) New funding: Curi Bio raised $6 million to further develop its human stem cell-based platforms for drug discovery. Dynamk Capital led the Series A round. Total funding to date is $16.8 million. Company backgro ...

2021-03-18 - Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms

SEATTLE, March 18, 2021 /PRNewswire/ -- Curi Bio Inc., a leading developer of human stem cell-based platforms for drug discovery, announced today it has raised $6 million in a Series A financing round. The round, led by Dynamk Capital, is expected to close with additional investors by the end of ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.6M52-13%$5M
#2
$6.8M52N/AN/A
#3
$6.6M52-24%N/A
#4
$12.4M522%N/A
#5
$4M5221%$6M